ALNY vs SBLX · P/E 76, rev $1.29B vs rev $63.8K
Alnylam Pharmaceuticals Inc (ALNY) versus StableX Technologies, Inc. (SBLX) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
StableX Technologies, Inc. (SBLX) is a auto manufacturers company listed on NASDAQ.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported SBLX revenue for 2024-12-31 was $63.8K. Net income was -$1.8M. Revenue was down 87.2% from 2023-12-31 to 2024-12-31. SBLX currently screens at market cap $4.5M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. SBLX currently screens at market cap $4.5M.
Not investment advice. Open the ALNY and SBLX stock pages for the full models.
Not investment advice.